Society for ImmunoTherapy in Cancer (SITC)
Make your mark at the largest cancer immunotherapy conference and exhibit at SITC's 39th Annual Meeting, hosted by the leading member-driven organization focused on cancer immunotherapy, SITC. At SITC's Annual Meeting, we will bring together international leaders from academia, regulatory and government agencies, as well as industry representatives for unmatched education, scientific exchange and networking with the scientists driving the field.
Meet the Fortrea Team
While at the SITC, we invite you to meet with our team of oncology experts who will be on hand to discuss trials, pipeline, and challenges. The Fortrea team masters multiple disciplines and technologies for one purpose - to deliver experience and expertise to enable the best outcome for your trial. Our goal is to accelerate the progress of your drug, diagnostic and devices through a collaborative approach that delivers better data and unparalleled insights.
Geoffrey Kannan，哲学博士、医学博士
高级医疗主任
Geoffrey Kannan, PhD, MD, is an Executive Medical Director in the Oncology Therapeutic Area, Head of the Americas Oncology Team, and Lead for the Pediatric Oncology Medical Science Leadership Center. Dr. Kannan also provides medical and scientific governance to Sponsors, supporting development and execution of oncology clinical trials. Dr. Kannan brings more than 25 years of oncology scientific and medical experience to Fortrea. Dr. Kannan trained as a pediatric hematologist/oncologist and pediatric neuro-oncologist and has served at the University of Miami Miller School of Medicine, the University of Texas M. D. Anderson Cancer Center, Dana-Farber Cancer Institute/Boston Children's Hospital, and on faculty at Harvard Medical School. Dr. Kannan joined Fortrea out of practice as a pediatric neuro-oncologist affiliated with Inova Children's Hospital and Children's National Medical Center. At Fortrea Dr. Kannan leads medical and scientific oncology therapeutic expertise and strategic endeavors for Fortrea's Americas-based oncology physicians, and leads Fortrea's pediatric oncology initiatives, lending an experienced voice to guide industry partners to bring life-saving therapies to children afflicted with cancer.
